WO2010014267A2 - Method and structure for ameliorating side-effects of performing in situ fenestration using a plasma rf catheter - Google Patents
Method and structure for ameliorating side-effects of performing in situ fenestration using a plasma rf catheter Download PDFInfo
- Publication number
- WO2010014267A2 WO2010014267A2 PCT/US2009/035761 US2009035761W WO2010014267A2 WO 2010014267 A2 WO2010014267 A2 WO 2010014267A2 US 2009035761 W US2009035761 W US 2009035761W WO 2010014267 A2 WO2010014267 A2 WO 2010014267A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- radiofrequency
- electrode
- catheter
- stent graft
- plasma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
Definitions
- the present invention relates generally to use of stent-grafts, and more particularly to fenestration of a stent-graft in situ.
- a conventional main (vessel) stent-graft typically includes a radially expandable reinforcement structure, formed from a plurality of annular stent rings, and a cylindrically shaped layer of graft material, sometimes called graft cloth, defining a lumen, to which the stent rings are coupled.
- the stent rings includes straight portions that are referred to as struts.
- Main stent-grafts are well known for use in tubular shaped human vessels.
- endovascular aneurysmal exclusion is a method of using a main stent-graft to exclude pressurized fluid flow from the interior of an aneurysm. This reduces the risk of rupture of the aneurysm and the associated risk of mortality.
- Main stent-grafts with custom side openings are sometimes fabricated to accommodate particular vessel geometries of each individual patient. Specifically, as the location of branch vessels emanating from a main vessel, e.g., having the aneurysm, varies from patient to patient, main stent-grafts to treat such configurations are fabricated with side openings customized to match the position of the branch vessels of the particular patient. However, custom fabrication of main stent-grafts is relatively expensive and time consuming.
- main stent-grafts may be formed in situ.
- the main stent-graft is placed in the main vessel, e.g., the aorta, to exclude an aneurysm. Fenestrations may be made in situ to correspond to positions of the adjacent branch vessels. See US Patent 5,617,878 of Taheri.
- the graft material of the main stent-graft is pierced with a needle at the ostium of a branch vessel, e.g., the renal artery, emanating from the main vessel.
- a fenestration is typically initiated with a small needle perforation of the graft material.
- the perforation must be enlarged with a conical dilator.
- an expandable balloon is inserted in the needle perforation in the graft material of the main stent-graft.
- considerable force is required to expand the balloon and tear the graft material.
- a method includes using a radio frequency (RF) plasma catheter in a branch vessel which reduces adverse side effects during the in situ fenestration of a main-stent graft in a main vessel.
- the RF plasma catheter is used to create a fenestration in situ in a main stent graft when the branch vessel is blocked or covered by the main stent graft.
- a step contributing to reducing side effects includes injecting a pulse of a flush solution before, during and after the fenestration to create a micro environment of the flush solution about an RF electrode of the RF plasma catheter.
- a step contribution to reducing side effects also includes using an insulator in the RF plasma catheter to maintain a separation of the RF electrode from a strut of the main stent graft to prevent damage to the strut during creation of the fenestration.
- the injecting of a pulse of flush solution starts a flow of a flush solution through the RF plasma catheter.
- the fenestration is created in the stent graft cloth by applying power to the RF electrode of the RF plasma catheter at a time t1 after the starting of the flow.
- the flow of the flush solution is maintained while applying power.
- the flow of the flush solution is terminated at a time t2 after the application of power is stopped.
- the flow of flush solution washes blood away from the RF electrode and thereby reduces coagulum formed by the heating of blood associated with the application of power to the RF electrode.
- a radio frequency (RF) plasma catheter assembly includes a center liner bounding a lumen.
- a RF electrode is coupled to the center liner at a distal end of the center liner.
- the RF electrode bounds a lumen aligned to provide a flow path from the lumen of the center liner through the RF electrode.
- a source of a flush solution is Atty Ref No: P27435 PCT coupled to the center liner.
- An outer insulator is mounted about the RF electrode.
- a circumferential outer edge surface of the outer insulator comprises a portion of an outer circumferential edge surface of the RF catheter assembly.
- An inner insulator is mounted between the center liner and the RF electrode.
- the inner insulator bounds a lumen aligned to provide a flow path from the lumen of the center liner to the lumen of the RF electrode.
- the RF electrode includes a convex exterior edge surface. In another implementation, the RF electrode includes a concave exterior edge surface.
- Fig. 1 is a process flow diagram for one implementation of the method according to this invention.
- FIG. 2A is an illustration of a main stent graft in a main vessel where the main stent graft blocks profusion of a branch vessel.
- Fig. 2B is an illustration of an implementation of the RF plasma catheter being positioned in the branch vessel.
- FIG. 3A is a more detailed illustration of the position of the RF plasma catheter of Fig. 2B.
- Fig. 3B illustrates the flow of the flush solution for the configuration of Fig. 3A after the flow of flush solution is started.
- Fig. 3C illustrates the flow of the flush solution for the configuration of Fig. 3B after the applying of power to the RF electrode is started.
- Fig. 4 is a more detailed process flow chart associated with the implementation illustrated in Figs. 2A, 2C, and 3A to 3C.
- Fig. 5 is an example of timing for a pulse of flush solution with respect to timing of a RF pulse to the RF electrode.
- FIG. 6 is a schematic view of one example of a saline-assisted RF plasma electrode fenestration catheter assembly.
- FIG. 7 is an illustration of an implementation of the RF plasma catheter that includes an outer insulation for maintaining a separation between a stent strut and a RF electrode of the RF plasma catheter.
- Fig. 8 is a cross-sectional view of one implementation of a RF plasma catheter that includes a RF electrode with a convex exterior edge surface and an outer insulator.
- Fig. 9 is an illustration of convex exterior edge surface suitable for the RF electrode of Fig. 8.
- Fig. 10 is a cross-sectional view of one implementation of a RF plasma catheter that includes a RF electrode with a concave exterior edge surface and an outer insulator.
- a RF plasma catheter is used to cut out a portion of the graft cloth of the main-stent graft adjacent to an ostium of the branch vessel to be perfused.
- a RF plasma catheter is used to cut out a portion of the graft cloth of the main-stent graft adjacent to an ostium of the branch vessel to be perfused.
- a radio-frequency (RF) plasma catheter is configured to include at least one configuration of (1) a RF plasma catheter electrode bounded by an insulator and (2) a pulsed flush capability.
- the next step is, in Install Stent Graft step 120, a main stent graft in placed in a main vessel of a patient using well known techniques.
- step 130 cuts a portion out of the graft cloth of the main-stent graft adjacent to an ostium of the branch vessel to be perfused using the RF plasma catheter from step 110.
- step 130 is completed, the branch graft placement process continues as is known in the prior art and so is not described herein.
- the pulsed flush capability is used in step 130, a pulse of flush solution is injected through the RF plasma catheter so that blood is washed away from both the site of the fenestration and the RF plasma catheter electrode. If the RF plasma catheter electrode is bounded by an outer insulator, the stent struts are shielded from the plasma and the heat generated by the plasma. Thus, the possibility of cutting a main stent graft strut is reduced.
- the RF plasma catheter can include both the pulsed flush capability and the RF plasma catheter electrode circumferentially bounded by an outer insulator, which reduces both coagulum and the possibility of damaging a stent strut.
- FIG. 4 A more detailed example of process 100 using the pulsed flush capability is presented in describing Figs. 2A, 2B, 3A, 3B, 3C, and 4 to 6.
- a method 400 (Fig. 4) is used.
- the sequence of steps (processes) in method 400 is illustrative of one of several possibilities. In view of this disclosure, those of skill in the art can modify the sequence as appropriate for a particular procedure while still achieving the advantages of ameliorating side effects of using the RF plasma catheter for fenestration in situ.
- a main stent graft 230 (Fig. 2A) is placed in a vessel 210 of a patient - vessels such as the aorta and the branches such as innominate, left common carotid, and left subclavian arteries, but could be the arteries of the descending aorta as well.
- Vessel 210 includes an aneurysm 211.
- Main stent graft 230 includes a plurality of stent struts including stent strut 231 and stent graft cloth 232. The construction of main stent graft 230 is known to those of skill in the art.
- Main stent graft 230 blocks an ostium 221 of branch vessel 220. Thus, an opening in main stent graft 230 is needed to allow perfusion of branch vessel 220.
- a RF plasma catheter 240 (Fig. 2B) with a flush capability is inserted in the patient and positioned in branch vessel 220 (See Figs. 2B and 3A), using conventional techniques.
- a RF plasma catheter electrode sometimes referred to as RF electrode, of RF plasma catheter 240 is positioned adjacent and contacting stent graft cloth 332, as shown in more detail in Fig.
- RF plasma catheter 340 includes an annular body 342 bounding a channel 343, sometimes called lumen 343, which is coupled to a source of a flush solution.
- channel 343 is oriented along and about a longitudinal axis 344 of RF plasma catheter 340.
- RF electrode 341 also bounds a lumen that is aligned to provide a flow path from lumen 343 through said RF electrode 341.
- RF electrode 341 of RF plasma catheter 340 is coupled to a power supply similar to those used for cautery devices.
- RF electrode 341 is formed of an electrically conductive material.
- RF electrode 341 is formed of a super elastic memory material, e.g., nitinol.
- electrode 341 is formed of stainless steel.
- RF electrode 341 is formed of a radiopaque material to aid in visualization of RF electrode 341 using an imaging process, for example, so that RF electrode 341 is visible using x-rays.
- radiopaque materials from which RF electrode 341 can be formed include platinum-iridium, tantalum, gold, and stainless steel.
- an electrode (not shown)is coupled to the patient, typically a pad of electrically conducting saline hydrogel is affixed to the patient that is also coupled to the power supply. This electrode is called the ground or common electrode and is electrically connected to the patient, for example, using an electrically conductive gel.
- RF plasma catheter 340 with RF electrode 341 is not essential in this example so long as the RF plasma catheter is capable of creating an opening in graft cloth 332 using a plasma in conjunction with the pulsed flush of this example.
- RF plasma catheters suitable for use in method 400 are described more completely below, as well as in copending and commonly assigned, U.S. Patent Application Serial No. 11/557,204, entitled "Cutting Radio Frequency Catheter for Creating Fenestrations in Graft Cloth" of Walter Bruszewski and Patrick MacAulay filed on November 7, 2006.
- a flush solution 350 (Fig. 3B) is started through channel 343 in Inject Pulse Of Flush Solution step 425.
- the flow rate and pressure of flush solution 350 is chosen so that any blood in the vicinity is washed away from the region about RF electrode 341 in ostium 321 and from indentation 335 about RF electrode 341.
- Those of skill in art Atty Ref No: P27435 PCT will appreciate that the flow of flush solution 350 could also be started before RF electrode 341 is in position, e.g., in contact with graft cloth 332.
- flush solution 350 While the flow of flush solution 350 is maintained, power is applied to RF electrode 341 in create fenestration step 430. A plasma is created that results in a hole being cut in graft cloth 332, i.e., creates fenestration 336 (Fig. 3C). The heat from the plasma fuses the edges of fenestration 336. As illustrated in Fig. 3C, flush solution 350 flows through fenestration 336 into the interior volume of main stent graft 330.
- step 425 starts a flush solution pulse 510.
- time period t1 at time T-RF pulse Start, power is applied to RF electrode 341 in step 430 and power is maintained until time T-RF pulse End.
- step 435 stops flush solution flow at time Tend.
- the vertical displacements in Fig. 5 have no meaning and are not intended to specify any relationship between the two pulses. Similarly, Fig. 5 is not intended to limit the option which might be considered for any specific pulse rise and fall times.
- the initial edge of the pulse of flush solution 510 starts to dilute the blood near RF electrode and the continued flow washes blood away from the fenestration site and away from RF electrode 341.
- pulse 510 prevents blood from reaching the fenestration site and RF electrode 341.
- the pulse of flush solution 510 washes blood away and blocks blood from the fenestration site and from RF electrode 341 while RF pulse 520 is active.
- the flush solution conducts the RF energy.
- time period t1 and time period t2 have a same duration, for example, 50 msec (milliseconds).
- the duration of RF pulse 520 is 1000 msec and so the duration of flush solution pulse 510 is 1100 msec.
- time period t1 and time period t2 can have different durations.
- dual balloons could be used to block blood follow through the main stent graft, use a dual core RF plasma catheter via the auxiliary vessel, inject saline in one core of catheter, open other core of catheter to use as saline drain, do the cutting, continue to inject saline and in this way flush all the coagulum, small particles of graft cloth etc. out and then unblock flow through stent graft.
- Fig. 6 is a schematic view of one example of a saline-assisted RF plasma electrode fenestration catheter assembly 640, sometimes referred to as RF plasma catheter 640, suitable for use in the methods described above.
- RF plasma catheter 640 includes RF electrode 641 at a proximal end of RF plasma catheter 640 and an operator's handle 616 includes three ports 643, 644, and 645 at a proximal end of RF plasma catheter 640.
- the distal end of RF plasma catheter 640 is referenced with respect to operator's handle 616.
- RF electrode 641 is electrically connected to an RF conductor (not shown) that in turn is connected to a receptacle in port 645.
- the RF conductor extends from the distal end to the proximal end of RF plasma catheter 640
- the RF conductor is a metal wire such as a copper, steel, NiTi, or stainless steel wire, or is formed of the same material as RF electrode 641.
- the RF conductor is welded or soldered to RF electrode 641 and is wound around an annular center liner (not shown).
- the annular center liner is coupled to RF electrode 641 so that a continuous channel for flow of flush Atty Ref No: P27435 PCT solution 650 is available.
- the wire can have a covering that is an insulator is, for example, a silicone elastomer, polyamide, or polyurethane.
- thermoplastic tubing are placed over the center liner and RF conductor and heat shrunk to form catheter shaft 642 that extends from RF electrode 641 to handle 616.
- the techniques for forming catheter shaft 642 with a center liner covered with thermoplastic tubing are equivalent to those used in the prior art and so are known to those of skill in the art in view of this description.
- techniques for providing power and flow channels through a catheter shaft are described in U.S. Patent No. 5,916,213, entitled “Systems and Methods for Tissue Mapping and Ablation," of Haissaguerre et al, issued on June 29, 1999, which is incorporated herein by reference as evidence of the level of skill in the art.
- the RF conductor is electrically connected to a RF power supply (not shown) through port 645 via RF power line 660.
- RF power line 660 is terminated by a banana jack that plugs into the receptacle in port 645.
- the RF power supply supplies RF power via RF power line 660 to the RF conductor and thus to RF electrode 641.
- the RF power supply operates in the 200 - 500 kHz frequency range.
- the power output of RF power supply is in the range of 50 to 300 watts and is capable of providing 100 to 300 watts/sec.
- the RF power supply is a Valleylab Cautery RF generator (Model Force FXTM Electrosurgical Generator manufactured by Valleylab - 5720 Longbow Dr., Boulder, CO) although any one of a number of RF generators can be used. Although particular frequency and power output ranges are provided, these are illustrative only.
- Port 644 is coupled to a source of flush solution such as a bag of saline.
- output flow 673 of the bag of saline is connected to an input port of saline pump 672.
- the output port of saline pump 672 is connected to a saline supply tube 671 that in turn is connected to saline inflow port 644.
- Port 644 is configured to provide the saline to the inner channel, sometimes called lumen, of catheter shaft 642.
- saline pump 672 is a roller pump. In another implementation, saline pump 672 is a positive displacement pump. Saline pump 672 Atty Ref No: P27435 PCT provides 50 to 100 ml/min flow with a pressure ranging between 2 and 15 atmospheres. The saline from saline bag 673 and saline pump 672 provide a source of flush solution 670.
- Port 643 is a Touhy-Borst adapter allows passage of the guidewire 646 which guides the catheter to the fenestration site, the guidewire can be pulled back during fenestration.
- guidewire 646 includes a catching structure (corkscrew like shaped structure) at a distal end of guidewire 646. As described in copending U.S. Patent Application Serial No. 1 1/557,204, the catching structure catches the flap of graft material cut from the graft material by RF electrode 641.
- a guidewire 646, e.g., a 0.035 inch guidewire, extends out the guidewire lumen of port 643.
- the guidewire 646 extends through the length of catheter shaft 642 in the channel described above. While no problem with electrical coupling with the guidewire has been detected, a guidewire may include a dielectric coating or be formed of a dielectric material or be enclosed in a guiding catheter. [0060] In another example to ameliorate adverse side effects of using a RF plasma catheter 740 (Fig. 7) for in situ fenestration, a RF plasma catheter electrode 741 of RF plasma catheter 740 is bounded by an outer insulator 745. Outer insulator 745 is a high temperature electrical insulator in this implementation.
- high temperature means that outer insulator 745 can be used in proximity to high temperature, because outer insulator 745 is a poor conductor of heat and so acts as an insulator from the high temperature as well as an electrical insulator.
- Outer insulator 745 causes RF electrode 741 to be separated from a main stent graft strut 731 while RF electrode 741 positively contacts, e.g., depresses, main stent graft cloth 742 during fenestration. This separation effectively shields stent strut 731 from the plasma created during fenestration and from the heat generated by the plasma.
- the potential for RF plasma catheter 740 to inadvertently cut strut 731 is greatly reduced, if not eliminated.
- Fig. 8 is a cross sectional view of a portion of one implementation of a RF plasma catheter 840 that includes an outer insulator 845 which will maintain separation between a stent strut and the RF electrode.
- RF plasma catheter 840 also includes RF electrode 841 , inner insulator 847, center liner 846, and catheter shaft body 842.
- Center liner 846 is a cylindrical annulus having an inner diameter 873 and an outer diameter 874. An inner circumferential edge surface of center lining 846
- PCT has diameter 873 and bounds channel 843, sometimes called lumen 843.
- Inner diameter 873 can range from 0.018 in) to 0.042 in) and in this implementation is 0.039 in).
- Outer diameter 874 can range from 0.022 in) to 0.046 in) and in this implementation is 0.043 in).
- Center liner 846 can be formed from a polymer tube such as polymide, stainless steel wire braid reinforced polyimide, polyamide, PEEK, or HDPE.
- Distal end 846A of center liner 846 is mounted within inner insulator 847.
- Inner insulator 847 is made from a material that functions as a high temperature electrical insulator.
- an ultra high temperature machineable ceramic is used to form inner insulator 847.
- the ultra high temperature machineable ceramic has the following properties: Max temp of 3100 0 F, thermal conductivity of 181 Btu/hr. x in./sq. ft..
- One ceramic suitable for use, Very High Temperature Nonporous High- Alumina Ceramics can be obtained from McMaster-Carr Industrial Supply, Santa Fe Springs, CA.
- inner insulator 847 is selected to insulate center liner 846 from the heat deposited in RF electrode 841 during fenestration so that the structural and physical integrity of center liner 846 is not compromised by that heat.
- inner insulator 847 includes an annular wall 847A with an exterior lip 847B about one end of annular wall 847A and an interior lip 847C about an opposite end of annular wall 847A.
- An inner diameter of annular wall 847A is selected based on outer diameter 874 of center liner 846 so that inner insulator 847 is affixed to center liner 846. Typically inner insulator 847 is bonded to outer liner 846 using high temperature epoxy adhesive.
- the outer diameter of annular wall 847A is 0.060 in. However, this value is illustrative only and in one implementation, the outer diameter is selected from a range of 0.040 in to 0.100 in.
- An outer diameter of exterior lip 847B and a length of exterior lip 847B along longitudinal axis 844 are selected to isolate center liner 846 from any heat conducted from annular section 841 B of RF electrode 841.
- the lip having length of 0.020 - 0.025 in. and a diameter of 0.070-0.080 in.
- An inner diameter of interior lip 847B is diameter 873.
- a length of interior lip 847B along longitudinal axis 844 is selected to isolate center liner 846 from any heat conducted from RF electrode 841.
- inner insulator 847 has a length 878 along longitudinal axis 844, which is 0.020-0.025 in. Atty Ref No: P27435 PCT
- Outer insulator 845 is a high temperature electrical insulator.
- the general shape of outer insulator 845 is annular with an inner edge surface modified as illustrated in Fig. 8 to facilitate affixing both outer insulator 845 and RF electrode 841 to RF plasma catheter 840 while insulating a stent strut adjacent to outer circumferential edge surface 845A from the heat and plasma associated with RF electrode 841.
- Outer insulator 845 is made from the same material as inner insulator 847.
- outer circumferential edge surface 845A has a length 876 along longitudinal axis of 0.010 - 0.030 in. However, this value is illustrative only. Exterior separation edge surface 845B has a length 872 approximately transverse to longitudinal axis 844 of 0.010 - 0.015 in. However, this value is illustrative only and in one implementation, the length is selected from a range of 0.13 mm (0.005 in) to 0.020 in. The inner diameter of outer insulator 845 is dependent on the thickness of annular wall 841 B of RF electrode 841.
- RF electrode 841 has a convex exterior edge surface 841 A, which in this implementation is a smooth arc. However, this illustrative only and is not intended to limit possible embodiments to this specific shape.
- Fig. 9 is illustrates an alternative convex exterior edge surface 941 A for RF electrode 941.
- RF electrode 841 has an inner circumferential edge surface with a diameter 873 so that as shown by the arrows in Fig. 8 saline can flow unimpeded through the lumens in each of center liner 843, inner insulator 847, and RF electrode 841.
- An annular wall 841 B of RF electrode 841 has an inner diameter so that annular portion 841 B fits about and is affixed to inner insulator 847 by high temperature epoxy adhesive.
- the outer diameter of annular wall 841 B is 0.070 in.
- a length 877 of annular wall 841 B is selected to facilitate affixing the wire used to supply power to RF electrode 841 and to affix RF electrode 841 securely to RF plasma catheter 840. In this implementation, length 877 is 0.050 in.
- Catheter shaft body 842 is formed as described above from thermoplastic tubing.
- Fig. 10 is a cross sectional view of a portion of another implementation of a
- RF plasma catheter 1040 that includes an outer insulator 1045 which will maintain separation between a stent strut and the RF electrode.
- RF plasma catheter 1040 also includes RF electrode 1041 , inner insulator 1047, center Atty Ref No: P27435 PCT liner 1046, and catheter shaft body 1042.
- Outer insulator 1045, inner insulator 1046, center liner 1046, and catheter shaft body 1042 are equivalent to outer insulator 845, inner insulator 847, center liner 846, and catheter shaft body 1042, respectively as described above and so that description is incorporated herein by reference.
- RF electrode 1041 is similar to RF electrode 841 , expect the exterior edge surface is a combination of a concave exterior edge surface 1041 A, which in this implementation is a smooth arc and an exterior ring edge surface 1041 B. However, this is illustrative only and is not intended to limit the possible embodiments to this specific shape.
Landscapes
- Health & Medical Sciences (AREA)
- Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Medical Informatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Electromagnetism (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Heart & Thoracic Surgery (AREA)
- Otolaryngology (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Materials For Medical Uses (AREA)
- Surgical Instruments (AREA)
- Prostheses (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011500846A JP5296188B2 (ja) | 2008-03-17 | 2009-03-02 | Rfプラズマカテーテルを用いて現場開窓を実施した場合の副作用を改善する方法及び構造体 |
| EP09803291.5A EP2262563B1 (en) | 2008-03-17 | 2009-03-02 | Structure for ameliorating side-effects of performing in situ fenestration using a plasma rf catheter |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12/049,522 | 2008-03-17 | ||
| US12/049,522 US8197475B2 (en) | 2008-03-17 | 2008-03-17 | Method and structure for ameliorating side-effects of performing in situ fenestration using a plasma RF catheter |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2010014267A2 true WO2010014267A2 (en) | 2010-02-04 |
| WO2010014267A3 WO2010014267A3 (en) | 2010-04-22 |
Family
ID=41063846
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2009/035761 Ceased WO2010014267A2 (en) | 2008-03-17 | 2009-03-02 | Method and structure for ameliorating side-effects of performing in situ fenestration using a plasma rf catheter |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US8197475B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2262563B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5296188B2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2010014267A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007127362A2 (en) * | 2006-04-26 | 2007-11-08 | The Cleveland Clinic Foundation | Apparatus and method for treating cardiovascular diseases |
| CA2679898C (en) | 2007-03-05 | 2014-11-18 | Alon Shalev | Multi-component expandable supportive bifurcated endoluminal grafts and methods for using same |
| US8540708B2 (en) | 2008-10-21 | 2013-09-24 | Hermes Innovations Llc | Endometrial ablation method |
| US9662163B2 (en) | 2008-10-21 | 2017-05-30 | Hermes Innovations Llc | Endometrial ablation devices and systems |
| CA3009244C (en) | 2009-06-23 | 2020-04-28 | Endospan Ltd. | Vascular prostheses for treating aneurysms |
| US11896282B2 (en) | 2009-11-13 | 2024-02-13 | Hermes Innovations Llc | Tissue ablation systems and method |
| US9358099B2 (en) * | 2009-11-30 | 2016-06-07 | Biflow Medical Ltd. | Method of implanting a stent graft and creating a fenestration therein |
| US8945203B2 (en) | 2009-11-30 | 2015-02-03 | Endospan Ltd. | Multi-component stent-graft system for implantation in a blood vessel with multiple branches |
| CA2789304C (en) | 2010-02-08 | 2018-01-02 | Endospan Ltd. | Thermal energy application for prevention and management of endoleaks in stent-grafts |
| US9545323B2 (en) | 2010-11-16 | 2017-01-17 | W. L. Gore & Associates, Inc. | Fenestration devices, systems, and methods |
| US9839510B2 (en) | 2011-08-28 | 2017-12-12 | Endospan Ltd. | Stent-grafts with post-deployment variable radial displacement |
| WO2013065040A1 (en) | 2011-10-30 | 2013-05-10 | Endospan Ltd. | Triple-collar stent-graft |
| EP2785277B1 (en) | 2011-12-04 | 2017-04-05 | Endospan Ltd. | Branched stent-graft system |
| WO2013171730A1 (en) | 2012-05-15 | 2013-11-21 | Endospan Ltd. | Stent-graft with fixation elements that are radially confined for delivery |
| WO2014108895A2 (en) | 2013-01-08 | 2014-07-17 | Endospan Ltd. | Minimization of stent-graft migration during implantation |
| WO2014141232A1 (en) | 2013-03-11 | 2014-09-18 | Endospan Ltd. | Multi-component stent-graft system for aortic dissections |
| US10603197B2 (en) | 2013-11-19 | 2020-03-31 | Endospan Ltd. | Stent system with radial-expansion locking |
| BR112017012425A2 (pt) | 2014-12-18 | 2018-01-02 | Endospan Ltd | enxerto por stent endovascular com tubo lateral resistente à fadiga |
| CN120770992A (zh) * | 2018-06-13 | 2025-10-14 | 南微医学科技股份有限公司 | 一种热穿刺支架置入器 |
| US11554214B2 (en) | 2019-06-26 | 2023-01-17 | Meditrina, Inc. | Fluid management system |
| US12426910B2 (en) | 2022-09-14 | 2025-09-30 | Medtronic Vascular, Inc. | In-situ fenestration devices with ultrasonic cutter |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01262876A (ja) * | 1988-04-11 | 1989-10-19 | Genesberg Robert | 血管カテーテル |
| FR2638364A1 (fr) * | 1988-10-27 | 1990-05-04 | Farcot Jean Christian | Appareillage pour la realisation d'une angioplastie prolongee |
| US5984907A (en) | 1995-06-05 | 1999-11-16 | Ep Technologies, Inc. | Transition sleeve assembly for catheters |
| US6036687A (en) * | 1996-03-05 | 2000-03-14 | Vnus Medical Technologies, Inc. | Method and apparatus for treating venous insufficiency |
| US5617878A (en) | 1996-05-31 | 1997-04-08 | Taheri; Syde A. | Stent and method for treatment of aortic occlusive disease |
| TW312294U (en) | 1996-08-07 | 1997-08-01 | Wei Zhuang | Structure of electrode for electric knife |
| US5916213A (en) | 1997-02-04 | 1999-06-29 | Medtronic, Inc. | Systems and methods for tissue mapping and ablation |
| US6200312B1 (en) * | 1997-09-11 | 2001-03-13 | Vnus Medical Technologies, Inc. | Expandable vein ligator catheter having multiple electrode leads |
| US6120476A (en) * | 1997-12-01 | 2000-09-19 | Cordis Webster, Inc. | Irrigated tip catheter |
| US6210406B1 (en) * | 1998-12-03 | 2001-04-03 | Cordis Webster, Inc. | Split tip electrode catheter and signal processing RF ablation system |
| US6626899B2 (en) * | 1999-06-25 | 2003-09-30 | Nidus Medical, Llc | Apparatus and methods for treating tissue |
| US6379350B1 (en) * | 1999-10-05 | 2002-04-30 | Oratec Interventions, Inc. | Surgical instrument for ablation and aspiration |
| US6413256B1 (en) * | 2000-08-01 | 2002-07-02 | Csaba Truckai | Voltage threshold ablation method and apparatus |
| US6955657B1 (en) | 2001-12-31 | 2005-10-18 | Advanced Cardiovascular Systems, Inc. | Intra-ventricular substance delivery catheter system |
| US7310545B1 (en) | 2002-04-12 | 2007-12-18 | Medtronic, Inc. | Method and device to form a sensor using isolated cardiomyocytes |
| JP4598184B2 (ja) | 2005-02-09 | 2010-12-15 | Hoya株式会社 | 内視鏡用高周波処置具 |
| US20070219576A1 (en) | 2006-03-16 | 2007-09-20 | Medtronic Vascular, Inc. | Reversibly and Radially Expandable Electroactive Polymer Element for Temporary Occlusion of a Vessel |
| US8048071B2 (en) * | 2006-09-29 | 2011-11-01 | Baylis Medical Company Inc | Method for creating a channel through a foreign material |
| US7963960B2 (en) | 2006-11-07 | 2011-06-21 | Medtronic Vascular, Inc. | Cutting radio frequency catheter for creating fenestrations in graft cloth |
| TWM312294U (en) | 2006-11-24 | 2007-05-21 | New Deantronics Taiwan Ltd | Electrode structure of electric knife |
-
2008
- 2008-03-17 US US12/049,522 patent/US8197475B2/en active Active
-
2009
- 2009-03-02 WO PCT/US2009/035761 patent/WO2010014267A2/en not_active Ceased
- 2009-03-02 EP EP09803291.5A patent/EP2262563B1/en not_active Not-in-force
- 2009-03-02 JP JP2011500846A patent/JP5296188B2/ja not_active Expired - Fee Related
Non-Patent Citations (1)
| Title |
|---|
| See references of EP2262563A4 * |
Also Published As
| Publication number | Publication date |
|---|---|
| US8197475B2 (en) | 2012-06-12 |
| EP2262563A4 (en) | 2011-04-06 |
| JP5296188B2 (ja) | 2013-09-25 |
| JP2011516113A (ja) | 2011-05-26 |
| US20090234348A1 (en) | 2009-09-17 |
| WO2010014267A3 (en) | 2010-04-22 |
| EP2262563A2 (en) | 2010-12-22 |
| EP2262563B1 (en) | 2016-08-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8197475B2 (en) | Method and structure for ameliorating side-effects of performing in situ fenestration using a plasma RF catheter | |
| US12185961B2 (en) | Electrically enhanced retrieval of material from vessel lumens | |
| JP6463816B2 (ja) | ブロックステントデバイスおよび使用方法 | |
| EP3019105B1 (en) | Devices for nerve modulation | |
| EP3941366B1 (en) | Electrically enhanced retrieval of material from vessel lumens | |
| US7963960B2 (en) | Cutting radio frequency catheter for creating fenestrations in graft cloth | |
| US20170296260A1 (en) | Ablation medical device with basket | |
| US8292885B2 (en) | Family of electrodes for use in performing in situ fenestration using a plasma RF catheter | |
| EP3363398A1 (en) | Cutting system for medical treatment | |
| US11826089B2 (en) | Compression stent device and methods | |
| CN116133621A (zh) | 用于治疗分叉部动脉瘤的用于植入物的插入系统 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09803291 Country of ref document: EP Kind code of ref document: A2 |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2011500846 Country of ref document: JP |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| REEP | Request for entry into the european phase |
Ref document number: 2009803291 Country of ref document: EP |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2009803291 Country of ref document: EP |